5NT1A (N-Term) antibody
| Antigen | 5NT1A |
| Binding Site |
N-Term |
| Clonality | Polyclonal |
| Host |
Rabbit |
| Reactivity |
Human |
| Application |
Western Blotting (WB), Immunohistochemistry (IHC)
|
![]() |
1 reference available |
| Certificates | ISO 9001:2008 |
| Catalog no. | ABIN653871 |
| Quantity | 0.1 mg (0.25 mg/ml) |
| Price | 280.50 $ Plus shipping costs $45.00 |
| Shipping to |
|
| Availability | Will be delivered in 2 to 3 Business Days |
Additional Information
| Gene ID | 84618 |
| UniProt | Q9BXI3 |
| Immunogen | This 5NT1A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 98~127 amino acids from the N-terminal region of human 5NT1A. |
| Isotype | Ig |
| Description | Other names: Cytosolic 5'-nucleotidase IA, cN-IA, cN-I, Cytosolic 5'-nucleotidase 1A, cN1A,NT5C1A |
| Characteristics | Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab) |
| Specificity | This 5NT1A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 98~127 amino acids from the N-terminal region of human 5NT1A. |
| Molecular Weight | 41021 DA |
| Comments |
Background: Cytosolic nucleotidases, such as NT5C1A, dephosphorylate nucleoside monophosphates. |
Application Details
| Application Notes | The suggested dilution is: ELISA ~~ 1:1,000 Western blotting~~ 1:100~500 Immunohistochemistry ~~ 1:50~100 |
| Concentration | 0.25 mg/ml |
| Purification | Purified |
| Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
| Storage | Maintain refrigerated at 2-8 deg C for up to 6 months. For long term storage store at -20 deg C in small aliquots to prevent freeze-thaw cycles |
| Research Area | Chromatin, Signaling, Metabolism, Cell Structure |
| Restrictions | For Research Use only |
Images
Publications
| Product |
Landers, Melki, Meininger et al.: "Reduced expression of the Kinesin-Associated Protein 3 (KIFAP3) gene increases survival in sporadic amyotrophic lateral sclerosis." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 106, Issue 22, pp. 9004-9, 2009 (PubMed).
|




